The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 166-172

  Oiso, Hiroshi ^a   Furukawa, Noboru ^a   Suefuji, Mihoshi ^a   Shimoda, Seiya ^a   Ito, Akihiro ^b   Furumai, Ryohei ^b   Nakagawa, Junichi ^c   Yoshida, Minoru ^b   Nishino, Norikazu ^d   Araki, Eiichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^d KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Forkhead box O 1 (FoxO1); HDAC inhibitor; HDAC1; Hepatocyte nuclear factor 4 (HNF4 ); Phosphoenol pyruvate carboxykinase (PEPCK)

Indexed keywords

GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE INHIBITOR; INSULIN; KY 2; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; PYRUVIC ACID; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG INHIBITION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INSULIN TOLERANCE TEST; LIPID DIET; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ANIMALS; BLOOD GLUCOSE; CELL LINE, TUMOR; FORKHEAD TRANSCRIPTION FACTORS; GLUCONEOGENESIS; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITORS; HUMANS; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; PEPTIDES, CYCLIC; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHORYLATION; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

MUS;

EID: 78650892668     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.086     Document Type: Article

References (26)

1. Pilkis S.J., Granner D.K. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 1992, 54:885-909.
2. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
3. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
4. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
5. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8Å resolution. Nature 1997, 389:251-260.
6. Turner B.M. Cellular memory and the histone code. Cell 2002, 111:285-291.
7. Sengupta N., Seto E. Regulation of histone deacetylase activities. J. Cell. Biochem. 2004, 93:57-67.
8. Dokmanovic M., Marks P.A. Prospects: histone deacetylase inhibitors. J. Cell. Biochem. 2005, 96:293-304.
9. Glozak M.A., Sengupta N., Zhang X., Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005, 363:15-23.
10. Minucci S., Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 2006, 6:38-51.
11. Chuang D.M., Leng Y., Marinova Z., Kim H.J., Chiu C.T. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 2009, 32:591-601.
12. Barnes P.J., Adcock I.M., Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. 2005, 25:552-563.
13. Gray S.G., De Meyts P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab. Res. Rev. 2005, 21:416-433.
14. Yoshizaki T., Milne J.C., Imamura T., Schenk S., Sonoda N., Babendure J.L., Lu J.C., Smith J.J., Jirousek M.R., Olefsky J.M. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol. Cell. Biol. 2009, 29:1363-1374.
15. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
16. Frescas D., Valenti L., Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 2005, 280:20589-20595.
17. Nakae J., Cao Y., Daitoku H., Fukamizu A., Ogawa W., Yano Y., Hayashi Y. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J. Clin. Invest. 2006, 116:2473-2483.
18. Liang F., Kume S., Koya D. SIRT1 and insulin resistance. Nat. Rev. Endocrinol. 2009, 5:367-373.
19. Nishino N., Jose B., Shinta R., Kato T., Komatsu Y., Yoshida M. Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors. Bioorg. Med. Chem. 2004, 12:5777-5784.
20. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., Hedrick S., Xu W., Boussouar F., Brindle P., Takemori H., Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
21. Accili D., Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117:421-426.
22. Lane A.A., Chabner B.A. Histone deacetylase inhibitors in cancer therapy. J. Clin. Oncol. 2009, 27:5459-5468.
23. Torres-Padilla M.E., Sladek F.M., Weiss M.C. Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4alpha mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J. Biol. Chem. 2002, 277:44677-44687.
24. Hatzis P., Talianidis I. Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression. Mol. Cell. Biol. 2001, 21:7320-7330.
25. Maeda Y., Hwang-Verslues W.W., Wei G., Fukazawa T., Durbin M.L., Owen L.B., Liu X., Sladek F.M. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. Biochem. J. 2006, 400:303-313.
26. Xie X., Liao H., Dang H., Pang W., Guan Y., Wang X., Shyy J.Y., Zhu Y., Sladek F.M. Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs. Mol. Endocrinol. 2009, 23:434-443.